Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Therapeutic strategies targeting B-cells in multiple sclerosis.
Self-esteem is associated with perceived stress in multiple sclerosis patients.
Recognizing and overcoming potential barriers to oral medications for MS.
Natural antisense RNAs are involved in the regulation of CD45 expression in autoimmune diseases.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Promoting Physical Activity through a Manual Wheelchair Propulsion Intervention in Persons with Multiple Sclerosis.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Restless legs syndrome as the initial presentation of multiple sclerosis.
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
Diffuse astrocytoma arising within a demyelinating plaque.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic.
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics.
Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
Intractable vomiting as an initial presentation of lupus-related neuromyelitis optica.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.

Pages